Connection Capital backs HEL

With the fresh capital, the company will boost its organic growth, extend its market penetration and expand in fast-growing markets, including Asia.

Following the deal, Connection Capital will select a new chair to help drive the business forward, while HEL CEO Jasbir Singh will stay on with the company and continue to lead the business.

Company
Founded in 1987 and based in Borehamwood, HEL designs and manufactures custom-made modular lab instruments and testing equipment. The company services a range of chemical, pharmaceutical and biotech corporates, and academic and research institutions worldwide, including Pfizer, GlaxoSmithKline, Shell, Dow, MIT, the University of Cambridge and the Industrial Technology Research Institute.

HEL employs 51 staff and contractors, and has offices in the US, India and China. In 2017, the company generated a turnover of £8m and expects to reach revenues of approximately £10.6m in 2018.

People
HEL – Jasbir Singh (CEO).
Connection Capital – Luke Matthews (investment director).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Expansion
• UK / Ireland
• Healthcare
• United Kingdom
• Venture